A Phase 1, Open Label, Single Dose, Randomized, Cross Over Study To Estimate The Absolute Oral Bioavailability Of CP-690,550 In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 09 Aug 2010
At a glance
- Drugs Tofacitinib; Tofacitinib
- Indications Ankylosing spondylitis; Crohn's disease; Plaque psoriasis; Psoriatic arthritis; Renal transplant rejection; Rheumatoid arthritis; Ulcerative colitis
- Focus Pharmacokinetics
- 09 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 Aug 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Jul 2010 Additional trial location [Singapur] identified as reported by ClinicalTrials.gov.